Delivery Order SPE2DB22D3501-SPE2DB24FTE49
Award Date 10/13/23
Potential Completion Date 10/16/23
Potential Value $752
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $619.11 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of PYLERA. PYLERA is a medication used to treat Helicobacter pylori infection and associated duodenal ulcer disease. The delivery order was awarded under an indefinite-delivery/indefinite-quantity contract vehicle and calls for shipment of the medication to a location in Conshohocken, Pennsylvania by June 26, 2023 to support the DLA's medical supply needs. No...
- The Defense Logistics Agency awarded a $926.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 PYLERA capsules. PYLERA is a prescription medication used to treat Helicobacter pylori infection and is commonly procured by DLA under its pharmaceutical contracts portfolio. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period concluding on August 28, 2023. No set aside designation or subcontracting details were...
- The Defense Logistics Agency awarded a delivery order valued at $1,856.19 to AmerisourceBergen Drug Corp for PYLERA Capsule UU 120S (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride), an antibiotic combination therapy. This contract represents a firm fixed-price delivery order with no set-aside designation, issued competitively on January 14, 2026, with an ultimate completion date of January 15, 2026. The award will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $795.53 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 PYLERA capsules. PYLERA is a medication used to treat Helicobacter pylori infection and is commonly procured by the DOD to support military treatment facilities. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with delivery required by August 4, 2023. The award was made using the Federal Supply Schedule, a multiple award indefinite...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,922 to Amerisourcebergen Drug Corporation to supply 120 PYLERA capsules. PYLERA is a medication used to treat Helicobacter pylori infection and is commonly procured by DLA under its pharmaceutical contracts on behalf of the Department of Defense. As the prime contractor, Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania with performance required by August 29,...
- The Defense Logistics Agency awarded a $12,742 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 PYLERA capsules. PYLERA is a triple combination antibiotic used to treat Helicobacter pylori infection. Under this order, Amerisourcebergen will deliver the capsules to a location in Conshohocken, Pennsylvania by August 9, 2023 to support the DLA's medical supply needs. As a top pharmaceutical distributor, Amerisourcebergen regularly fulfills delivery orders from the DLA...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $606.18 to Amerisourcebergen Drug Corp for 120 PYLERA capsules. PYLERA is a medication used to treat Helicobacter pylori infection and is likely being procured to support the DLA's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corp, the prime contractor performing under the contract with production facilities located in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a $1,897 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of PYLERA. PYLERA is used to treat Helicobacter pylori infection and is commonly procured by DLA under its pharmaceutical contracts to support various Department of Defense treatment programs. As a major pharmaceutical distributor, Amerisourcebergen will fulfill this order from its facilities in Conshohocken, Pennsylvania by the scheduled completion date of...
- The Defense Logistics Agency Troop Support Medical awarded a $2,919.49 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of PYLERA. PYLERA is used to treat Helicobacter pylori infection and will be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 22, 2023 in fulfillment of this order. As a major pharmaceutical supplier, Amerisourcebergen supports the DLA's provision of medical supplies and medications to military treatment...
- The Defense Logistics Agency awarded a $31,188.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of PYLERA, used to treat Helicobacter pylori infection. The contract has a period of performance from August 14 to August 15, 2023, with all work taking place in Conshohocken, Pennsylvania. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the global supply chain for the U.S. military and supports its readiness...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FTE49Delivery Order
This delivery order for $751 worth of PYLERA CAPSULE UU 120S was awarded on October 13, 2023 by the Defense Logistics Agency to Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania. The order is for 120 capsules of PYLERA, which contains the active ingredients bismuth subsalicylate, metronidazole, and tetracycline hydrochloride and is used to treat Helicobacter pylori infection and associated duodenal ulcer disease. The contract has a firm fixed price and is scheduled for completion by October 16, 2023. No set-aside designation was used for this award made under an existing DLA vehicle.
Generated 1/12/24, 9:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $752 | 10/13/23 |